Loading viewer...
investor_presentation
Format: PDF investor_presentation
4 Q 1 9 a n d F u l l -Y e a r 2 0 1 9 E a r n i n g s C a l l P r e s e n t a t i o n F e b r u a r y 2 7 , 2 0 2 0
4 Q 1 9 a n d F u l l -Y e a r 2 0 1 9
E a r n i n g s C a l l P r e s e n t a t i o n
F e b r u a r y 2 7 , 2 0 2 02
Thispresentation (and oralstatements regarding thesubject matter ofthispresentation) includes forward -looking statements
intended toqualify under the“safe harbor” from liability established bythePrivate Securities Litigation Reform Actof1995.
These forward -looking statements include any statements reflecting Quanta's expectations, intentions, strategies,
assumptions, plans orbeliefs about future events orperformance orthatdonotsolely relate tohistorical orcurrent facts.
Forward -looking statements involve certain risks, uncertainties andassumptions thataredifficult topredict orbeyond Quanta's
control, andactual results maydiffer materially from those expected, implied orforecasted byourforward -looking statements
duetoinaccurate assumptions andknown andunknown riskanduncertainties .Foradditional information concerning some of
therisks, uncertainties, assumptions andother factors thatcould affect ourforward -looking statements, please refer to
Quanta’s most recently filedAnnual Report onForm 10-K,recently filedQuarterly Reports onForm 10-Qandother documents
filedwiththeSecurities andExchange Commission, which areavailable onourwebsite (www .quantaservices .com), aswellas
therisks, uncertainties andassumptions identified inthispresentation .Investors andanalysts should notplace undue reliance
onQuanta’s forward -looking statements, which arecurrent only asofthedate ofthispresentation .Quanta does not
undertake andexpressly disclaims anyobligation toupdate orrevise anyforward -looking statements toreflect events or
circumstances after thedateofthispresentation orotherwise, andQuanta expressly disclaims anywritten ororalstatements
made byanythird party regarding thesubject matter ofthispresentation .
Certain information maybeprovided inthispresentation thatincludes financial measurements thatarenotrequired by,or
presented inaccordance with, generally accepted accounting principles (GAAP) .These non-GAAP measures should notbe
considered asalternatives toGAAP measures, such asnetincome andcash flowprovided byoperating activities, andmaybe
calculated differently from, andtherefore maynotbecomparable to,similarly titled measures used atother companies .Fora
reconciliation tothemost directly comparable GAAP financial measures, please refer toQuanta’s fourth quarter andfullyear
2019 earnings release available atwww.quantaservices .comandtheappendix ofthispresentation .
Theinformation contained inthisdocument hasnotbeen audited byanyindependent auditor .Thispresentation isprepared
asaconvenience forsecurities analysts andinvestors andmaybeuseful asareference tool.Quanta mayelect tomodify the
format ordiscontinue publication atanytime, without notice tosecurities analysts orinvestors .3
Call Participants and Agenda
President and Chief Executive Officer
Chief Financial Officer
Preview truncated — download the full document for the complete content.
investor_presentation
55 Pages
investor_presentation
42 Pages
Sanoma
Tonix Pharmaceuticals Holding Investor Presentation — March 2017
investor_presentationinvestor_presentation
30 Pages
Tonix Pharmaceuticals Holding Corp.
Investor Webinar
investor_presentationinvestor_presentation
Minerals 260 Limited